Alkermes is seeking an experienced Program Manager to support our ALKS 2680 program which is currently in Phase 2 development and preparing for Phase 3 and registration. ALKS 2680 is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development as a once-daily treatment for narcolepsy and idiopathic hypersomnia. This person will work closely with members across our organization including areas such as research, pre-clinical, clinical, pharmaceutical development, regulatory affairs, medical affairs, commercial, operations, policy and government affairs, patient engagement and corporate communications, as well as the senior management team to orchestrate development and execution of our fully-integrated program strategic and operational plans to support key corporate goals including the development and ultimate approval of ALKS 2680 as well as identify and execute a comprehensive lifecycle management program.
This is a hybrid on-site position based at our Waltham, MA office.
Areas of responsibility will include:
- Facilitates development and execution of fully-integrated program strategic and operational plans, including:
- Development of program strategy, business objectives, activities to achieve these, and potential constraints with team recommendations for how to address
- Identifies cross-functional linkages/potential gaps, supports team with optimization of plans and execution
- Given the phase of this program the ideal candidate will have previous experience with late-stage development and registration submission preparation and support
- Proactive management of project execution as well as facilitating and maintaining comprehensive risk management plans
- Provides strong project management support to ensure issues are resolved by the team and communication / escalation is executed as needed
- Facilitates an innovative solution-oriented mindset and transparency across the business
- Facilitates an enterprise mindset within the team and drives strong cross-functional prioritization and decision making
- Development of program strategy, business objectives, activities to achieve these, and potential constraints with team recommendations for how to address
- Provides leadership and overall program management support to the product team and key sub-teams
- Development and maintenance of program budgets, timelines, and communication tools/documents used by the team and senior management to ensure strong communication and integrated logistical operations across the business
- Contributes to enhancement and innovation of program management systems and processes to support the evolving needs of our teams and the broader organization
We’re looking for an individual who values the team dynamic, is organizationally savvy, excels in a matrixed-management/leadership environment, and enjoys working on the details without losing site of the larger organizational goals.
Basic Requirements:
- BS/MS in a scientific or engineering discipline, with 12+ years of relevant pharmaceutical product development experience
Preferred Requirements:
- Prior experience managing product teams across the drug product lifecycle continuum from early-stage through late-stage candidate development, as well as commercial and lifecycle management; including support and maintenance of program strategic plans as well as product timeline and budgetary management responsibility
- Prior experience working on regulatory submissions
- Expert knowledge of MS Project, MS Excel; knowledge of Planview and SmartSheet would be beneficial
- Exceptional verbal/written communication, time/resource management, attention to detail, interpersonal and organization skills
#LI-HB1
About Us
Why join Team Alkermes?
Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we are committed to pursuing great science, driven by deep compassion to make a real impact in the lives of patients. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for various neurological disorders, including narcolepsy.
Beyond our important mission of developing medicines to address unmet patient needs, we actively seek to foster a culture of diversity, inclusion and belonging throughout our business. We strive to ensure that all voices are respected and valued, recognizing that our diversity of thought, background and perspective makes us stronger. We are proud to have been recognized as an employer of choice by many national organizations, including being certified as a Great Place to Work in the U.S. in 2024, honored as a Healthiest Employer in both Ohio and Massachusetts in 2023, a Best Place for Working Parents in 2023, and to have received the Bell Seal at the Platinum level for Workplace Mental Health by Mental Health America for three consecutive years (2021-2023).
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
